About InCephalo
InCephalo is a company based in Allschwil (Switzerland) founded in 2021 by Carlo Bertozzi.. InCephalo offers products and services including In C01 and C-Lock Technology. InCephalo operates in a competitive market with competitors including Imvax, GT Medical Technologies, Basilea, Laminar Pharma and SOM Biotech, among others.
- Headquarter Allschwil, Switzerland
- Founders Carlo Bertozzi
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of InCephalo
InCephalo offers a comprehensive portfolio of products and services, including In C01 and C-Lock Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats brain cancers by enhancing local immune response with reduced toxicity.
Enables localized biologics retention in CNS to minimize systemic side effects.
Funding Insights of InCephalo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by InCephalo
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - InCephalo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Incephalo Comparisons
Competitors of InCephalo
InCephalo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imvax, GT Medical Technologies, Basilea, Laminar Pharma and SOM Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Patient-specific cell vaccines for glioma treatment are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for brain tumor radiation therapy are provided.
|
|
| domain | founded_year | HQ Location |
Antibiotics, antifungals, and oncology drugs are developed for disease treatment.
|
|
| domain | founded_year | HQ Location |
Melipathy-based drugs are developed for cancer, Alzheimer's, and inflammation treatments.
|
|
| domain | founded_year | HQ Location |
Developer of platform for screening compounds to treat rare diseases
|
|
| domain | founded_year | HQ Location |
Therapeutic drugs for cancer, eye, and infectious diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about InCephalo
When was InCephalo founded?
InCephalo was founded in 2021.
Where is InCephalo located?
InCephalo is headquartered in Allschwil, Switzerland. It is registered at Allschwil, Basel-landschaft, Switzerland.
Who is the current CEO of InCephalo?
Carlo Bertozzi is the current CEO of InCephalo. They have also founded this company.
What does InCephalo do?
InCephalo was founded in 2021 in Allschwil, Switzerland, within the biotechnology sector. Therapeutics targeting neurological disorders are developed, with a focus on proprietary Compartment Lock technology that retains locally applied biologics behind the blood-brain barrier. Operations center on advancing drug candidates for brain-related conditions. The lead product, IL-12, functions as a proinflammatory cytokine to regulate anti-tumor immune responses in brain cancer treatments.
Who are the top competitors of InCephalo?
InCephalo's top competitors include Imvax, GT Medical Technologies and Basilea.
What products or services does InCephalo offer?
InCephalo offers In C01 and C-Lock Technology.